Anika Therapeutics, Inc.
ANIK· Nasdaq
ANIKAnika Therapeutics, Inc.
Filed May 6, 2013 · 10-Q · 36 days after period end · 0001157523-13-002386
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $15.25M | $14.36M | $11.74M |
| Net Income | $3.07M | $1.91M | $324.41K |
| EPS Diluted | $0.21 | $0.14 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 6, 2013 · 36 d after period end
